What is Akari Therapeutics PLC (AKTX) stock price today?

Akari Therapeutics PLC (AKTX) currently trades at $5.35 per share. The stock has a market capitalization of $6.00M and a P/E ratio of 0.00x.

Is AKTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Akari Therapeutics PLC has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

AKTX

Akari Therapeutics PLC

NASDAQ: AKTX · HEALTHCARE · BIOTECHNOLOGY

$5.35

+2.10% today

Updated 2026-04-30

Market cap

$6.00M

P/E ratio

0.00

P/S ratio

478,368.50x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$3 – $59

Volume

0.3M

Market cap

$6.00M

P/E ratio

0.00

P/S ratio

478,368.50x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$3 – $59

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$153.39

+2767.10%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.04M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-17.75M	$-10.01M	$-19.79M	$-17.30M	$-5.30M
EPS	—	—	—	—	$0.00
Free cash flow	$-21.50M	$-16.43M	$-12.55M	$-10.57M	$-3.04M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AKTX	$6.00M	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Akari Therapeutics PLC trades at $5.35. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is Akari Therapeutics PLC's stock price?

Akari Therapeutics PLC (AKTX) trades at $5.35.

Is Akari Therapeutics PLC overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Akari Therapeutics PLC (AKTX)?

The analyst target price is $153.39, representing +2767.1% upside from the current price of $5.35.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio478,368.50x

ROE-68.40%

Beta0.54

50D MA$6.95

200D MA$21.18

Shares out0.00B

Float35.25B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AKTX vs LLY →AKTX vs JNJ →AKTX vs ABBV →Stock screener →